Rana al-Hallaq

Rana Al-Hallaq is an accomplished professional with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as Director on multiple Boards, including Triplet Therapeutics, ReCode Therapeutics, and Vivet Therapeutics, Rana has held various leadership roles at Pfizer since July 2015, advancing from Director of Business Development to Partner at Pfizer Ventures and Executive Director of Worldwide Business Development. In addition to contributions at Pfizer, Rana has been involved with several organizations as an Observer or Director, including Jnana Therapeutics and Montis Biosciences. Rana holds a PhD in Neuroscience from Georgetown University and a BA in Biology from Hamilton College.